CLASS III Device recall · Reported 9 May 2018 · FDA Enforcement Report
Alere iScreen Dx Urine Drug Screen Card recalled by Ameditech
Ameditech is recalling Alere iScreen Dx Urine Drug Screen Card, distributed in 9 states. The recall was initiated on 15 Dec 2017 and the FDA has classified it as Class III.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1542-2018
- FDA event ID
- 79549
- Recalling firm
- Ameditech, San Diego, CA
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 15 Dec 2017
- FDA classified
- 28 Apr 2018
- Reported
- 9 May 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Device type
- Other Medical Devices
Timeline
| 15 Dec 2017 | Recall initiated by company | |
| 28 Apr 2018 | Classified by FDA | +134 days |
| 9 May 2018 | Published in enforcement report | +11 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.
Product as listed by the FDA
Alere iScreen Dx Urine Drug Screen Card
Where it was distributed
Distributed domestically to AZ, FL, IL, ND, NV, PA, TN, TX, VA.
ArizonaFloridaIllinoisNorth DakotaNevadaPennsylvaniaTennesseeTexasVirginia
Questions about this recall
Why was it recalled?
The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.
Which lots are affected?
Part No. X11-IS10-Dx, Lot No. 173351, 173686, 174055, 176002.
Where was it sold?
Distributed domestically to AZ, FL, IL, ND, NV, PA, TN, TX, VA.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Ameditech
All 109| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | CLIA Waived Rapid Drug Test (AMT recalled by Ameditech | Ameditech | Potency & Assay | Nationwide |
| Device | CLASS II | First Check 1 Panel Drug Cup: (THC) recalled by Ameditech | Ameditech | Potency & Assay | Nationwide |
| Device | CLASS II | Fastect¿ II Drug Screen Dipstick Test Single Drug Detection (AMT recalled | Ameditech | Potency & Assay | Nationwide |
| Device | CLASS II | Alere iCup Drug Detection (AMT recalled by Ameditech | Ameditech | Potency & Assay | Nationwide |
| Device | CLASS II | MicroScreen (AMT recalled by Ameditech | Ameditech | Potency & Assay | Nationwide |
Other Other Medical Devices recalls
All 13,857| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Medline Convenience Kits: Major Pack recalled by Medline Industries | Medline Industries | Other | Nationwide |
| Device | CLASS II | Medline Convenience Kits: Peds Sinus Pack recalled by Medline Industries | Medline Industries | Other | Nationwide |
| Device | CLASS II | SmartPath to dStream for XR and 3.0T recalled by Philips North America | Philips North America | Device Malfunction | Nationwide |
| Device | CLASS II | Achieva 1.5T, Achieva 1.5T Conversion recalled by Philips North America | Philips North America | Device Malfunction | Nationwide |
| Device | CLASS II | Medline Convenience Kits: Mfc Craniotomy Pack recalled | Medline Industries | Other | Nationwide |